CLIA

LIAISON® & LIAISON XL® System

LIAISON® Meridian H. pylori SA

The LIAISON® Meridian H. pylori SA assay is a chemiluminescent immunoassay (CUA) intended for the qualitative determination of Helicobacter pylori (H. pylori) antigen in human stool. The test is an aid in the diagnosis of patients suspected of H. pylori infection and to measure post therapy response from patients who have discontinued therapy for at least 4 weeks.

Undefined

LIAISON® QuantiFERON® -TB Gold Plus

Il test DiaSorin LIAISON® QuantiFERON®-TB Gold Plus utilizza la tecnologia di immunodosaggio in chemiluminescenza (CLIA) per la rilevazione dell’interferone-γ (IFN-γ) in campioni di plasma umano prelevati in litio eparina. L’immunodosaggio può identificare le risposte in vitro a un cocktail di antigeni peptidici associati all’infezione da Mycobacterium tuberculosis (M. tuberculosis) che stimola le cellule del sangue intero eparinizzato raccolto con le provette QuantiFERON® Blood Collection Tubes (provette per prelievo ematico).

Undefined

LIAISON® XL MUREX Anti-HDV

The LIAISON® XL murex Anti-HDV assay uses chemiluminescence immunoassay (CLIA) technology for the qualitative detection of total antibodies
to hepatitis D virus in human serum and plasma samples. The assay results, in conjunction with other laboratory results and clinical information,
are intended to be used as an aid in the diagnosis of HDV infection and as a screening test for organ and tissue donors.

Undefined

LIAISON® H. pylori IgG

The LIAISON® H. pylori IgG kit uses chemilumineshent immunoassay (CLIA) technology for the qualitative determination of IgG antibodies to Helicobacter pylori in human serum samples.
The test has to be performed on the LIAISON® Analyzer family.

Undefined

Pages

Subscribe to RSS - CLIA